No Data
Longboard Pharmaceuticals Downgraded to Neutral From Buy at B. Riley
A Quick Look at Today's Ratings for Longboard Pharmaceuticals(LBPH.US), With a Forecast Between $60 to $60
Express News | Longboard Pharmaceuticals: If Deal Is Terminated Under Some Circumstances, Co Required to Pay H. Lundbeck A/S Termination Fee of $86.1 Mln
Baird Downgrades Longboard Pharmaceuticals to Neutral From Outperform, Price Target Is $60
Lundbeck to Acquire Longboard Pharmaceuticals for $2.6bn
Express News | Longboard Pharmaceuticals Inc : Truist Securities Cuts to Hold From Buy
No Data
No Data
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
101715680 : Give 20 days sure drop